RecruitingNCT05745805

Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China


Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Enrollment

600 participants

Start Date

Jan 12, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to establish a database of post-COVID-19 based on simultaneous cortico-spinal magnetic resonance imaging data to identify high-risk patients with long COVID and prevent the neurological symptoms evolution, optimize the tactics of management in China.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria1

  • Confirmed diagnosis of mild Covid-19 (WHO criteria)/Confirmed diagnosis of moderate Covid-19 (WHO criteria)/Healthy people who have not had COVID-19

Exclusion Criteria1

  • History of central nervous system diseases, such as mental disorder, degenerative diseases of central nervous system, tumors, trauma, etc. Participants with indication for MRI studies

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESimultaneous cortico-spinal magnetic resonance imaging, Serum

Simultaneous cortico-spinal magnetic resonance imaging data were collected in a strong magnetic field and collected the serum of participants.


Locations(1)

First Affiliated Hospital of Xian Jiaotong University

Xi'an, Shaanxi, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05745805


Related Trials